{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:08:15Z","timestamp":1769764095918,"version":"3.49.0"},"reference-count":15,"publisher":"Georg Thieme Verlag KG","issue":"01","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":951,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avicenna J Med"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hodgkin Lymphoma (HL) is a systemic disease with involvement of the cervical, supraclavicular, and mediastinal lymph nodes. It is commonly diagnosed in patients within the second and third decades of their lives. Diagnosis is usually made based on the distinct morphological and immunohistochemical characteristics, with the tissue biopsy being the cornerstone of workup. Extranodal presentation of HL is unusual and seldom encountered. Primary HL of the central nervous system (CNS) is exceedingly rare. We herein report a case of a 38yearold male patient who was diagnosed with primary CNSHL. The patient was treated with complete surgical resection followed by radiotherapy and chemotherapy. The patient was diseasefree for 7 years postoperatively without any clinical evidence of relapse. We also discussed a possible role of CNS regulatory Tcells (Tregs) in developmental primary CNSHL.<\/jats:p>","DOI":"10.4103\/ajm.ajm_104_18","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T04:25:07Z","timestamp":1535689507000},"page":"28-31","source":"Crossref","is-referenced-by-count":10,"title":["Primary central nervous system Hodgkin Lymphoma: A case discussion and a hypothesis on the etiology"],"prefix":"10.1055","volume":"9","author":[{"given":"Ahmad","family":"Alfaseh","sequence":"additional","affiliation":[{"name":"Department of Urology, Kidney Surgical Hospital, Damascus, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhd Nabeel","family":"Rajeh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Saint Louis University School of Medicine, St. Louis, MO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghiath","family":"Hamed","sequence":"additional","affiliation":[{"name":"Hematogenix Laboratory Services, Tinley Park, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2007.12.5088","article-title":"CNS involvement in Hodgkin\u2019s lymphoma","volume":"25","author":"D Re","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4172\/2165-7831.1000196","article-title":"Primary central nervous system involvement in classical Hodgkin\u2019s lymphoma: Case report and review of the literature","volume":"8","author":"K Z Cecyn","year":"2017","journal-title":"J Blood Lymph"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1080\/08830185.2017.1357719","article-title":"CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ","volume":"37","author":"N Negi","year":"2018","journal-title":"Int Rev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"108394","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease","volume":"82","author":"A D Reynolds","year":"2007","journal-title":"J Leukoc Biol"},{"key":"ref5","first-page":"20935","article-title":"The role of regulatory T cells in cancer","volume":"9","author":"T Y Ha","year":"2009","journal-title":"Immune Netw"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"113740","DOI":"10.4049\/jimmunol.167.3.1137","article-title":"Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells","volume":"167","author":"C A Piccirillo","year":"2001","journal-title":"J Immunol"},{"key":"ref7","first-page":"60612","article-title":"Increase of regulatory T cells in the peripheral blood of cancer patients","volume":"9","author":"A M Wolf","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"175562","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"N A Marshall","year":"2004","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"146773","DOI":"10.1158\/1078-0432.CCR-04-1869","article-title":"Outcome in Hodgkin\u2019s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells","volume":"11","author":"T Alvaro","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"193200","DOI":"10.3324\/haematol.11702","article-title":"Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center like diffuse large B cell lymphoma, follicular lymphoma and classical Hodgkin\u2019s lymphoma","volume":"93","author":"A Tzankov","year":"2008","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1200\/JCO.2009.23.0680","article-title":"Revisiting the prognostic value of regulatory T cells in patients with cancer","volume":"27","author":"C Badoual","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hon.878","article-title":"Prognostic impact of tumourinfiltrating th2 and regulatory T cells in classical Hodgkin lymphoma","volume":"27","author":"S Schreck","year":"2009","journal-title":"Hematol Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1002\/ccr3.66","article-title":"Classical Hodgkin lymphoma involving the central nervous system (brain) an unusual presentation","volume":"2","author":"S A van Blydenstein","year":"2014","journal-title":"Clin Case Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"165861","DOI":"10.1182\/blood-2008-04-151563","article-title":"CNS Hodgkin lymphoma","volume":"112","author":"E R Gerstner","year":"2008","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"36149","DOI":"10.1007\/s12032-012-0299-4","article-title":"Increased expression of CD4+CD25+FOXP3+ regulatory T cells correlates with Epstein Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil","volume":"29","author":"M C Assis","year":"2012","journal-title":"Med Oncol"}],"container-title":["Avicenna Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/ajm.AJM_104_18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T20:07:46Z","timestamp":1720555666000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/ajm.AJM_104_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":15,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.4103\/ajm.ajm_104_18","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2231-0770","2249-4464"],"issn-type":[{"value":"2231-0770","type":"print"},{"value":"2249-4464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}